DK1411960T3 - Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed - Google Patents

Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed

Info

Publication number: DK1411960T3
Authority: DK; Denmark
Prior art keywords: rice bran; grams; per; milligrams; vitamin
Prior art date: 2001-07-02

Application number

DK02749618T

Other languages

English (en)

Inventor

Diane Wright Hoffpauer

Salmon L Wright

Original Assignee

Diane Wright Hoffpauer

Salmon L Wright

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-02

Filing date

2002-06-21

Publication date

2006-07-24

2002-06-21 Application filed by Diane Wright Hoffpauer, Salmon L Wright filed Critical Diane Wright Hoffpauer

2006-07-24 Application granted granted Critical

2006-07-24 Publication of DK1411960T3 publication Critical patent/DK1411960T3/da

Links

235000007164 Oryza sativa Nutrition 0.000 title abstract 11
235000009566 rice Nutrition 0.000 title abstract 11
235000013305 food Nutrition 0.000 title abstract 3
240000007594 Oryza sativa Species 0.000 title 1
230000036996 cardiovascular health Effects 0.000 title 1
241000209094 Oryza Species 0.000 abstract 10
241001465754 Metazoa Species 0.000 abstract 3
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical group OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
208000024172 Cardiovascular disease Diseases 0.000 abstract 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
229930003451 Vitamin B1 Natural products 0.000 abstract 1
229930003779 Vitamin B12 Natural products 0.000 abstract 1
229930003268 Vitamin C Natural products 0.000 abstract 1
229930003427 Vitamin E Natural products 0.000 abstract 1
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
229960000304 folic acid Drugs 0.000 abstract 1
235000019152 folic acid Nutrition 0.000 abstract 1
239000011724 folic acid Substances 0.000 abstract 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
235000020660 omega-3 fatty acid Nutrition 0.000 abstract 1
229940012843 omega-3 fatty acid Drugs 0.000 abstract 1
239000006014 omega-3 oil Substances 0.000 abstract 1
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
229960003495 thiamine Drugs 0.000 abstract 1
DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
235000010374 vitamin B1 Nutrition 0.000 abstract 1
239000011691 vitamin B1 Substances 0.000 abstract 1
235000019163 vitamin B12 Nutrition 0.000 abstract 1
239000011715 vitamin B12 Substances 0.000 abstract 1
235000019158 vitamin B6 Nutrition 0.000 abstract 1
239000011726 vitamin B6 Substances 0.000 abstract 1
235000019154 vitamin C Nutrition 0.000 abstract 1
239000011718 vitamin C Substances 0.000 abstract 1
235000019165 vitamin E Nutrition 0.000 abstract 1
239000011709 vitamin E Substances 0.000 abstract 1
229940046009 vitamin E Drugs 0.000 abstract 1
229940011671 vitamin b6 Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Mycology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Oil, Petroleum & Natural Gas (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Plant Substances (AREA)
Cereal-Derived Products (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK02749618T 2001-07-02 2002-06-21 Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed DK1411960T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/895,335 US6436431B1 (en)	2001-07-02	2001-07-02	Fortified rice bran food product and method for promoting cardiovascular health

Publications (1)

Publication Number	Publication Date
DK1411960T3 true DK1411960T3 (da)	2006-07-24

Family

ID=25404356

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02749618T DK1411960T3 (da)	2001-07-02	2002-06-21	Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed

Country Status (13)

Country	Link
US (1)	US6436431B1 (da)
EP (1)	EP1411960B1 (da)
JP (1)	JP4300109B2 (da)
AT (1)	ATE322276T1 (da)
CA (1)	CA2451704C (da)
DE (1)	DE60210465T2 (da)
DK (1)	DK1411960T3 (da)
ES (1)	ES2262820T3 (da)
IL (2)	IL159370A0 (da)
MX (1)	MXPA03012035A (da)
NO (1)	NO20035850L (da)
PT (1)	PT1411960E (da)
WO (1)	WO2003004044A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6616942B1 (en) *	1999-03-29	2003-09-09	Soft Gel Technologies, Inc.	Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US6623734B2 (en) *	2000-06-22	2003-09-23	Soft Gel Technologies, Inc.	Super absorption coenzyme Q10
FR2847472B1 (fr) *	2002-11-22	2006-08-11	Synergia	Nouvelles compositions pharmaceutiques notamment pour la prevention des pathologies cardio-vasculaires
EP1617734A1 (en) *	2003-04-17	2006-01-25	Boehringer Ingelheim International GmbH	Multi-vitamin and mineral supplement for pregnant women
US20080089877A1 (en) *	2003-08-14	2008-04-17	Udell Ronald G	Super Absorption Coenzyme Q10
US8124072B2 (en)	2003-09-29	2012-02-28	Soft Gel Technologies, Inc.	Solubilized CoQ-10
US7169385B2 (en) *	2003-09-29	2007-01-30	Ronald G. Udell	Solubilized CoQ-10 and carnitine
EP1670325A1 (en)	2003-09-29	2006-06-21	Soft Gel Technologies, Inc.	SOLUBILIZED CoQ-10
US20050074443A1 (en) *	2003-10-03	2005-04-07	Treadwell Benjamin V.	Methods of attenuating autoimmune disease and compositions useful therefor
US7416752B2 (en) *	2004-01-06	2008-08-26	Sharp Ingrained Functional Foods, Inc.	Method of fortifying seeds with an essential fatty acid, fortified seed and food product
US20050147730A1 (en) *	2004-01-06	2005-07-07	Holub Bruce J.	Method of fortifying seeds with an essential fatty acid, fortified seed and food product
US20050267091A1 (en) *	2004-05-25	2005-12-01	Roger Berlin	Compositions containing policosanol and niacin and/or niacin derivatives and their pharmaceutical uses
US20060009486A1 (en) *	2004-07-07	2006-01-12	Gm Pharmaceuticals Inc.	Composition and method for treatment and prevention of coronary artery disease
US8101587B2 (en) *	2004-08-12	2012-01-24	Everett Laboratories, Inc.	Kits for nutrition supplementation
US7700142B2 (en) *	2005-05-16	2010-04-20	Diane Wright Hoffpauer	Fortified cereal bran to promote digestive health
US7887852B2 (en) *	2005-06-03	2011-02-15	Soft Gel Technologies, Inc.	Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
US20080038385A1 (en) *	2006-03-13	2008-02-14	Nutracea	Therapeutic uses of an anti-cancer composition derived from rice bran
US20070212470A1 (en) *	2006-03-13	2007-09-13	Nutracea	Therapeutic uses of an anti-cancer composition derived from rice bran
WO2008016701A2 (en) *	2006-08-02	2008-02-07	Hammond Neal A	Biogenic silica from silica-containing plant material such as rice hulls
FI122915B (fi)	2006-09-06	2012-08-31	Cerefi Oy	Kylläisyyttä aiheuttava tuote
US8343541B2 (en)	2007-03-15	2013-01-01	Soft Gel Technologies, Inc.	Ubiquinol and alpha lipoic acid compositions
US20080305214A1 (en) *	2007-06-08	2008-12-11	Barilla G. E R. Fratelli S.P.A.	Composition useful for the reduction of the cardiovascular risk and foods that contain it
EP2014180A1 (en)	2007-07-08	2009-01-14	Barilla G. e R. Fratelli S.p.A.	Composition useful for the reduction of the cardivascular risk and foods that contain it
JPWO2009011158A1 (ja) *	2007-07-18	2010-09-16	サンスター株式会社	米糠様組成物及び食品
JP5463526B2 (ja) *	2008-03-21	2014-04-09	国立大学法人東京海洋大学	健康機能成分を吸着・濃縮した乾燥脱脂穀類糠、該糠から調製した健康機能成分の濃縮物、及びそれらの製造方法
KR101938326B1 (ko)	2017-07-21	2019-04-11	한국식품연구원	합성 카라멜 색소를 사용하지 않은 떡갈비 조성물 및 이의 제조방법
RU2020128641A (ru) *	2018-02-02	2022-02-28	Сосьете Де Продюи Нестле С.А.	Стабилизация омега-3 жирных кислот с помощью отрубей
US20210260147A1 (en) *	2020-02-25	2021-08-26	Intermark Partners Strategic Management, Llc	Mitigation of chronic infant malnutrition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE59107305D1 (de)	1990-05-22	1996-03-07	Harold Bumann	Verfahren zur herstellung eines fruchtsaft-getränkes
US5326569A (en) *	1992-12-23	1994-07-05	Abbott Laboratories	Medical foods for the nutritional support of child/adult metabolic diseases
IT1274734B (it)	1994-08-25	1997-07-24	Prospa Bv	Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
US5545414A (en) *	1995-03-22	1996-08-13	Abbott Laboratories	Cholesterol lowering food product
US5612074A (en) *	1995-12-21	1997-03-18	Leach; Robin L.	Nutrient fortified food bar
US5948443A (en)	1996-02-23	1999-09-07	Medical Doctor's Research Institute, Inc.	Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
TW360501B (en)	1996-06-27	1999-06-11	Nestle Sa	Dietetically balanced milk product
EP0969743B1 (en) *	1997-03-20	2004-09-15	Coventry Group, Ltd.	Nutritional supplement for cardiovascular health
US6180660B1 (en)	1997-08-26	2001-01-30	Merck & Co., Inc.	Cholesterol-lowering therapy
AU9209898A (en)	1997-09-02	1999-03-22	Ricex Company, Inc., The	A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
US5952393A (en)	1998-02-12	1999-09-14	Sorkin, Jr.; Harlan Lee	Composition for reducing serum cholesterol levels
US6210686B1 (en)	1998-12-18	2001-04-03	Beth Israel Deaconess Medical Center	Dietary supplement and method for lowering risk of heart disease
ATE257332T1 (de) *	1999-03-18	2004-01-15	Bristol Myers Squibb Co	Vitamin formulierung für kardiovaskuläre gesundheit

2001
- 2001-07-02 US US09/895,335 patent/US6436431B1/en not_active Expired - Lifetime
2002
- 2002-06-21 MX MXPA03012035A patent/MXPA03012035A/es active IP Right Grant
- 2002-06-21 DK DK02749618T patent/DK1411960T3/da active
- 2002-06-21 AT AT02749618T patent/ATE322276T1/de not_active IP Right Cessation
- 2002-06-21 IL IL15937002A patent/IL159370A0/xx active IP Right Grant
- 2002-06-21 CA CA2451704A patent/CA2451704C/en not_active Expired - Fee Related
- 2002-06-21 JP JP2003510055A patent/JP4300109B2/ja not_active Expired - Fee Related
- 2002-06-21 EP EP02749618A patent/EP1411960B1/en not_active Expired - Lifetime
- 2002-06-21 WO PCT/US2002/019589 patent/WO2003004044A1/en active IP Right Grant
- 2002-06-21 DE DE60210465T patent/DE60210465T2/de not_active Expired - Lifetime
- 2002-06-21 PT PT02749618T patent/PT1411960E/pt unknown
- 2002-06-21 ES ES02749618T patent/ES2262820T3/es not_active Expired - Lifetime
2003
- 2003-12-15 IL IL159370A patent/IL159370A/en not_active IP Right Cessation
- 2003-12-30 NO NO20035850A patent/NO20035850L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1411960A1 (en)	2004-04-28
EP1411960A4 (en)	2004-11-03
JP4300109B2 (ja)	2009-07-22
MXPA03012035A (es)	2005-08-16
IL159370A0 (en)	2004-06-01
IL159370A (en)	2006-07-05
EP1411960B1 (en)	2006-04-05
NO20035850L (no)	2004-03-01
WO2003004044A1 (en)	2003-01-16
ES2262820T3 (es)	2006-12-01
PT1411960E (pt)	2006-08-31
DE60210465D1 (de)	2006-05-18
CA2451704A1 (en)	2003-01-16
ATE322276T1 (de)	2006-04-15
CA2451704C (en)	2012-07-17
US6436431B1 (en)	2002-08-20
DE60210465T2 (de)	2006-11-30
JP2004537302A (ja)	2004-12-16

Publication	Publication Date	Title
DK1411960T3 (da)	2006-07-24	Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed
DE60019722D1 (de)	2005-06-02	Pharmazeutische zusammensetzungen zur unbehagenverminderung
DE60229286D1 (de)	2008-11-20	Lebensmittel oder tierfutter enthaltend die knochengesundheit unterstützendes pflanzenextrakt aus amelanchier
MXPA01013210A (es)	2004-06-03	Composiciones farmaceuticas y nutricionales que contienen acidos grasos esenciales y agentes que disminuyen en la homocisteina.
CA2372614A1 (en)	2000-12-07	Process and product for enhancing immune response in companion animal using a combination of antioxidants
CY1108342T1 (el)	2014-02-12	Ανοσορρυθμιστικοι ολιγοσακχαριτες
MXPA04009765A (es)	2006-04-28	Metodo para mejorar la absorcion de la vitamina e por una mascota animal.
WO2006002976A3 (en)	2006-03-30	Canine osteoarthritis diet formulation
MXPA05009933A (es)	2005-11-04	Composiciones que comprenden acidos grasos y aminoacidos.
CY1112547T1 (el)	2015-12-09	Μεσα που περιεχουν φολικο οξυ, βιταμινη β6 και βιταμινη β12, και η χρηση αυτων
BR0013958A (pt)	2002-05-14	Dieta de elevado teor de lipìdios
TW200505470A (en)	2005-02-16	Therapeutic agent
TW200510308A (en)	2005-03-16	Isophthalic acid derivatives
HK1075654A1 (en)	2005-12-23	Hyperforin derivatives, the use thereof and formulations containing them
ATE112276T1 (de)	1994-10-15	Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
WO2000073274A3 (de)	2001-04-19	Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung als adenosinaufnahme-inhibitoren
UY27475A1 (es)	2003-06-30	Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización
DE60209793D1 (de)	2006-05-04	Modifierte methioninereiche nahrungsmittel und verfahren zu deren herstellung
RU2001111308A (ru)	2004-06-20	Способ профилактики нарушения белково-минерального обмена у телят при марганцевой недостаточности
WO2002096218A3 (de)	2003-05-01	Kombination von liponsäuren, carnitinen und kreatinen in lebens- und arzneimitteln
TH54050B (th)	2002-11-25	เอทิลอีพีเอ ที่ทำให้บริสุทธิ์อย่างมากและอนุพันธ์อีพีเออื่นๆ ที่ใช้รักษาโรคทางจิตเวชและโรคทางประสาท
TH54050A (th)	2002-11-25	เอทิลอีพีเอ ที่ทำให้บริสุทธิ์อย่างมากและอนุพันธ์อีพีเออื่นๆ ที่ใช้รักษาโรคทางจิตเวชและโรคทางประสาท
HUP9700432A2 (hu)	1998-11-30	Magnéziumot és vitaminokat tartalmazó készítmények